SI1933861T1 - Postopek za zdravjenje ali preprečevanje večorganske odpovedi - Google Patents

Postopek za zdravjenje ali preprečevanje večorganske odpovedi

Info

Publication number
SI1933861T1
SI1933861T1 SI200631388T SI200631388T SI1933861T1 SI 1933861 T1 SI1933861 T1 SI 1933861T1 SI 200631388 T SI200631388 T SI 200631388T SI 200631388 T SI200631388 T SI 200631388T SI 1933861 T1 SI1933861 T1 SI 1933861T1
Authority
SI
Slovenia
Prior art keywords
treating
organ failure
preventing multi
preventing
organ
Prior art date
Application number
SI200631388T
Other languages
English (en)
Slovenian (sl)
Inventor
Sirpa Jalkanen
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Publication of SI1933861T1 publication Critical patent/SI1933861T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200631388T 2005-10-07 2006-09-22 Postopek za zdravjenje ali preprečevanje večorganske odpovedi SI1933861T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20051003A FI20051003A0 (fi) 2005-10-07 2005-10-07 Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi
EP06794084A EP1933861B1 (en) 2005-10-07 2006-09-22 Method for treating or preventing multi-organ failure
PCT/FI2006/000308 WO2007042602A1 (en) 2005-10-07 2006-09-22 Method for treating or preventing ischemia reperfusion injury or multi-organ failure

Publications (1)

Publication Number Publication Date
SI1933861T1 true SI1933861T1 (sl) 2012-09-28

Family

ID=35185146

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631388T SI1933861T1 (sl) 2005-10-07 2006-09-22 Postopek za zdravjenje ali preprečevanje večorganske odpovedi

Country Status (14)

Country Link
EP (1) EP1933861B1 (da)
JP (2) JP5523707B2 (da)
CN (1) CN101282741B (da)
AU (1) AU2006301186B2 (da)
CA (1) CA2623518C (da)
CY (1) CY1113404T1 (da)
DK (1) DK1933861T3 (da)
ES (1) ES2389507T3 (da)
FI (1) FI20051003A0 (da)
HK (1) HK1125048A1 (da)
PL (1) PL1933861T3 (da)
PT (1) PT1933861E (da)
SI (1) SI1933861T1 (da)
WO (1) WO2007042602A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114630B2 (en) 2007-05-02 2012-02-14 Ambrx, Inc. Modified interferon beta polypeptides and their uses
FI20070795A0 (fi) 2007-10-24 2007-10-24 Faron Pharmaceuticals Oy Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
US8699141B2 (en) 2009-03-13 2014-04-15 Knowles Electronics, Llc Lens assembly apparatus and method
US8659835B2 (en) 2009-03-13 2014-02-25 Optotune Ag Lens systems and method
CN103228290A (zh) 2011-02-18 2013-07-31 (株)斯坦帝尔 包含沉默信息调节因子1表达诱导物质的败血症或者败血性休克的预防或者治疗用组合物
AU2019394810A1 (en) * 2018-12-04 2021-06-24 Faron Pharmaceuticals Oy Method for determining patient's responsiveness to type I interferon treatment and use of type I interferon to treat patient having specified single nucleotide polymorphism
KR20230136119A (ko) * 2021-01-25 2023-09-26 파론 파머수티컬스 오와이 Cd73을 상향 조절할 수 있는 약제 및 글루코코르티코이드의순차적 투여를 사용한 질환의 치료

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60129472T2 (de) * 2001-04-03 2008-04-17 U-Cytech B.V. Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon
WO2002089828A2 (en) * 2001-05-04 2002-11-14 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
CA2487038A1 (en) * 2001-06-11 2002-12-19 Transition Therapeutics Inc. Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
WO2003024399A2 (en) * 2001-09-18 2003-03-27 The Johns Hopkins University Specific depletion of cd4+t cells
US20060083715A1 (en) * 2002-03-12 2006-04-20 Steven Glazer Interferon beta-like molecules for treatment of stroke
CA2519465C (en) * 2003-03-28 2016-08-02 Faron Pharmaceuticals Oy Elevation of adenosine level by cytokine-induced expression of cd73

Also Published As

Publication number Publication date
EP1933861A4 (en) 2009-07-01
AU2006301186A1 (en) 2007-04-19
EP1933861B1 (en) 2012-08-08
FI20051003A0 (fi) 2005-10-07
JP2013028623A (ja) 2013-02-07
CN101282741A (zh) 2008-10-08
CA2623518C (en) 2014-11-18
AU2006301186B2 (en) 2011-08-04
JP5523707B2 (ja) 2014-06-18
PT1933861E (pt) 2012-08-20
JP2009511453A (ja) 2009-03-19
CA2623518A1 (en) 2007-04-19
ES2389507T3 (es) 2012-10-26
EP1933861A1 (en) 2008-06-25
WO2007042602A1 (en) 2007-04-19
HK1125048A1 (en) 2009-07-31
DK1933861T3 (da) 2012-10-15
CY1113404T1 (el) 2016-06-22
PL1933861T3 (pl) 2012-12-31
CN101282741B (zh) 2012-08-15

Similar Documents

Publication Publication Date Title
PL1877232T3 (pl) Sposób obróbki powierzchni drewna
HRP20150018T1 (hr) Postupak lijeäśenja ošteä†enja zglobova
EP1864785A4 (en) SETEROLITHOGRAPHIEVERFAHREN
GB0504774D0 (en) Method
GB0503836D0 (en) Method
IL183889A0 (en) Treatment method
GB0521319D0 (en) Method
GB0504096D0 (en) Method
GB0504184D0 (en) Method
EP2081437A4 (en) METHODS OF TREATING OR PREVENTING INFESTATION
PL1843880T3 (pl) Sposób obróbki drewna
SI1933861T1 (sl) Postopek za zdravjenje ali preprečevanje večorganske odpovedi
EP1883405A4 (en) METHODS OF TREATING NEPHROLITHIASIS
GB0505756D0 (en) Method
GB0502046D0 (en) Method
GB0515695D0 (en) Method
ZA200706456B (en) Method for treating liquids
GB0523431D0 (en) Method
GB0520981D0 (en) Method
GB0608357D0 (en) Method for treating effluent
GB0502901D0 (en) New detoxification method
GB0504182D0 (en) Method
GB0506670D0 (en) Method
GB0502360D0 (en) Method
EP1841443A4 (en) METHOD AND SYSTEM FOR TREATING HEART ERRORS